ConductScience.org, home

Gene · 1237

NIH grants1,226

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCCR8 papersNewest fiscal year
R01AI125247The role of IL-27/Lag3 axis in regulating Foxp3+ regulatory T cell function22025
R01AI151021Transcriptional Control of T Cell Function22025
R01HL118979Enhancing Treg Therapeutic Efficacy in GVHD22025
R01HL163984Noradrenergic mechanisms of IPF22025
R35CA196620Molecular mechanisms of antibody-mediated immunotherapies22025
R35HL145212Targeted Molecular Probes for Atherosclerosis Imaging and Therapy22025
R37AI034495In Vivo Prevention of Murine GVHD22025
T32AI007496Interdisciplinary Training Program in Immunology22025
T32AR007098Dermatology Training Grant22025
T32CA009501Surgical Oncology Research Training Grant22025
T32HL116275Research Training in Pulmonary Immunology and Allergy at Massachusetts General Hospital22025
U19AI057229Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro22025
U19AI057266Vaccine and Infection Induced Immunity in the Young and Aged22025
U19AI070235Epithelial Genes in Allergic Inflammation22025
U54CA1186381/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership22025
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success22025
ZIAAG000757Mechanisms Of Age-related Changes in Transcriptional Regulation in lymphocytes22025
ZIAAR041159Cytokine Signaling, Immunoregulation and Autoimmune and Immunodeficiency Diseases22025
ZIACP010135Studies of Non-Ionizing Radiation-Related Cancer22025
DP2AI154451Deciphering the specificity and molecular mechanisms of regulatory T cells using novel approaches12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1237/grants?page=2